ANTHELMINTIC ACTIVITY OF NOVEL ARYLSALICYLAMIDE DERIVATIVES


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. The incidence of intestinal helminthiases ranks fourth among diseases and injuries. Analysis of a range of anthelmintic drugs has shown that most of the agents registered in the Russian Federation are manufactured in foreign countries; the main drugs of which are salicylamide derivatives. Objective: to synthesize novel substituted salicylic acid amides with anthelmintic activity and to establish a structure-biological activity relationship. Material and methods. To identify the synthesized compounds, their melting point, UV and IR spectra in potassium bromide disks, and 1H NMR spectra in a DMSO-d6 solution were determined. Various methods for chromatographic analysis, such as TLC, GLC, HPLC, were also employed. Biological activity and toxicity were investigated in male albino mice. Results. The synthesized arylsalicylamides were found to have a higher anthelmintic activity than fenasal. Their acute toxicity (LD50) was determined; most of the synthesized compounds were practically non-toxic. A study of the relationship of their anthelmintic activity and toxicity to the structure showed that the amides containing chlorine atoms in the acid fragment were more active than those containing bromine atoms; replacing the methyl group in an amide to the alkoxy group in the arylamine fragment led to a decrease in acute toxicity and an increase in anthelmintic activity. Acetylation of phenolic hydroxyl arylsalicylamides reduced acute toxicity. Conclusion. The relationship of the anthelmintic activity and toxicity of arylsalicylamides to their structure was studied, which showed how the nature of the substituent in the salicyloyl and arylamine fragments affected toxicity and anthelmintic activity. 2,4-dichloro-6-([4-methyl-3chlorophenyl] carbamoyl)phenyl acetate was proposed to extend tests.

Full Text

Restricted Access

About the authors

Dmitrij P. Sevbo

Saint Petersburg State Chemopharmaceutical University

Professor of the Department of Pharmaceutical Chemistry 14, Prof. Popov St., Lit A, Saint Petersburg 197376, Russian Federation

Anna J. Malahova

Saint Petersburg State Chemopharmaceutical University

Email: annamalahova@yandex.ru
lecturer of the Department of Pharmaceutical Chemistry 14, Prof. Popov St., Lit A, Saint Petersburg 197376, Russian Federation

Vladimir N. Kuklin

Saint Petersburg State Chemopharmaceutical University

Email: кuklin-prof@yandex.ru
Professor of the Department of Pharmaceutical Chemistry 14, Prof. Popov St., Lit A, Saint Petersburg 197376, Russian Federation

References

  1. Лебедева М.Н., Михайлицын Ф.С., Сергеев В.П. Создание отечественных противопаразитарных препаратов. Медицинская паразитология и паразитарные болезни. 2001;4:13-6.
  2. Марушко Ю.В., Грачева М.Г. Современное состояние проблемы гельминтозов у детей. Вопросы диагностики и лечения. Современная педиатрия. 2012; 43: 21-6.
  3. Севбо Д.П., Малахова А.Ю., Куклин В.Н. Синтез строения арилсалициламидов, обладающих антигельминтной активностью. Бутлеровские сообщения, 2017; 9 (51): 115-24.
  4. Руководство по проведению доклинических исследований лекарственных средств. Часть 1. Под ред. А.Н. Миронова. М.: Гриф и К, 2012; 944.
  5. Прозоровский В.Б., Прозоровский М.П., Демченко В.М. Экспресс-метод определения средней эффективной дозы и ее ошибки. Фармакология и токсикология,1978; 4 (41): 407-509.
  6. Гицу Г.А., Малахова А.Ю., Михайлицын Ф.С. и др. Сравнительная оценка противогименолепидозной активности соединений ряда салициланилидов (бензамидов). Медицинская паразитология и паразитарные болезни, 2014;1: 44-45.
  7. Hodge H.C., Sterner J.H. Tabulation of toxicity classes. American Industrial Hygiene Association Journal. 1949; 10: 93-6.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies